- Home
- FHB vs VKTX Comparison
FHB vs VKTX Comparison
Compare FHB & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHB
- VKTX
- Stock Information
- Founded
- FHB 1858
- VKTX 2012
- Country
- FHB United States
- VKTX United States
- Employees
- FHB N/A
- VKTX N/A
- Industry
- FHB Major Banks
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- FHB Finance
- VKTX Health Care
- Exchange
- FHB Nasdaq
- VKTX Nasdaq
- Market Cap
- FHB 3.3B
- VKTX 3.5B
- IPO Year
- FHB 2016
- VKTX 2015
- Fundamental
- Price
- FHB $25.07
- VKTX $40.24
- Analyst Decision
- FHB Sell
- VKTX Strong Buy
- Analyst Count
- FHB 8
- VKTX 13
- Target Price
- FHB $26.81
- VKTX $86.92
- AVG Volume (30 Days)
- FHB 977.1K
- VKTX 4.6M
- Earning Date
- FHB 07-25-2025
- VKTX 07-23-2025
- Dividend Yield
- FHB 4.15%
- VKTX N/A
- EPS Growth
- FHB 11.02
- VKTX N/A
- EPS
- FHB 1.93
- VKTX N/A
- Revenue
- FHB $805,018,000.00
- VKTX N/A
- Revenue This Year
- FHB $10.34
- VKTX N/A
- Revenue Next Year
- FHB $2.65
- VKTX $338.60
- P/E Ratio
- FHB $13.00
- VKTX N/A
- Revenue Growth
- FHB 0.27
- VKTX N/A
- 52 Week Low
- FHB $20.32
- VKTX $18.92
- 52 Week High
- FHB $28.80
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- FHB 56.11
- VKTX 71.00
- Support Level
- FHB $23.57
- VKTX $31.30
- Resistance Level
- FHB $24.11
- VKTX $41.68
- Average True Range (ATR)
- FHB 0.46
- VKTX 2.11
- MACD
- FHB 0.06
- VKTX 0.63
- Stochastic Oscillator
- FHB 75.00
- VKTX 86.13
About FHB First Hawaiian Inc.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.